PD Dr. Markus Eckstein

Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie Institute of Pathology

Immune Cell Gene Expression Signature is Associated with Improved Outcome in Muscle-Invasive Urothelial Bladder Cancer Patients Treated with Radical Cystectomy (2020) Eckstein M, Strissel P, Strick R, Weyerer V, Wirtz RM, Pfannstiel C, Wullweber A, et al. Conference contribution EMT transcription factor ZEB1 alters the epigenetic landscape of colorectal cancer cells (2020) Lindner P, Paul S, Eckstein M, Hampel C, Muenzner JK, Erlenbach-Wuensch K, Ahmed HP, et al. Journal article Correction: Collective forces of tumor spheroids in three-dimensional biopolymer networks. (2020) Mark C, Grundy TJ, Strissel P, Böhringer D, Grummel N, Gerum R, Steinwachs J, et al. Journal article, Erratum Feasibility of sentinel lymph node detection by near-infrared endoscopy in squamous cell carcinoma of the oral cavity: A pilot study (2020) Sievert M, Goncalves M, Eckstein M, Iro H, Koch M Journal article Influence of p16 status on indication and outcome of salvage neck dissection in oropharyngeal cancer (2020) Müller SK, Mantsopoulos K, Semrau S, Agaimy A, Eckstein M, Traxdorf M, Gostian AO, et al. Journal article Establishment of Real-Time Multispectral Imaging for the Detection of Bladder Cancer Using a Preclinical in Vivo Model (2020) Meessen S, Rother J, Zheng X, Eckstein M, Kriegmair MC, Hernandez D, Grychtol B, et al. Journal article Pd1/pd-l1 axis in uro-oncology (2020) Junker K, Eckstein M, Fiorentino M, Montironi R Journal article, Review article FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment? (2020) van Rhijn BW, Mertens LS, Mayr R, Bostrom PJ, Real FX, Zwarthoff EC, Boormans JL, et al. Journal article Deep Learning Predicts Molecular Subtype of Muscle-invasive Bladder Cancer from Conventional Histopathological Slides (2020) Woerl AC, Eckstein M, Geiger J, Wagner DC, Daher T, Stenzel P, Fernandez A, et al. Journal article Multicentric Analytical and Inter-observer Comparability of Four Clinically Developed Programmed Death-ligand 1 Immunohistochemistry Assays in Advanced Clear-cell Renal Cell Carcinoma (2020) Sommer U, Eckstein M, Ammann J, Braunschweig T, Macher-Göppinger S, Schwamborn K, Hieke-Schulz S, et al. Journal article